The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Effective gene targeting in rabbits using RNA-guided Cas9 nucleases
Open accessAbstract
Dear Editor, Recently, zinc finger nuclease, transcription activator-like effector nuclease, and RNA-guided Cas9 endonuclease (Cas9) have emerged as powerful means for genome editing (Conklin, 2013; Gaj et al., 2013). These nucleases are efficient in generating double-strand breaks in the genome that can be repaired by error-prone nonhomologous end joining leading to a functional knockout (KO) of the targeted gene or used to integrate a DNA sequence at a specific locus through homologous recombination. Although the Cas9 system has been shown highly efficient in generating genetically engineered mice and rats (Li et al., 2013a, b; Wang et al., 2013), its feasibility in the rabbits still needs be determined. Here we report the use of Cas9 system to effectively generate targeted mutations in rabbit embryos and the production of KO rabbits. The rabbit is a classic model animal species. It is useful for the study of many human diseases such as atherosclerosis, cystic fibrosis, and acquired immunodeficiency syndrome. However, production of gene targeted transgenic (GTT) rabbits has been an extreme challenge. This is mainly due to the lack of germline transmitting embryonic stem cells and the very low efficiency of somatic cell nuclear transfer in rabbits (Chesne et al., 2002). In the present work, we used the Cas9 system to target the rabbit genome. Because embryo transfer work in large animal species is costly, we first established an in vitro system to test the efficacy of the RNA-guided Cas9 nucleases. Individual single guide RNAs (sgRNAs) were designed (Figure 1A and Supplementary Table S1) to target nine rabbit genes: apolipoprotein E (APOE), cluster of differentiation 36 (CD36), cystic fibrosis transmembrane conductance regulator, low-density lipoprotein receptor (LDLR), apolipoprotein CIII, scavenger receptor class B, member 1 (SCARB1), leptin, leptin receptor, and ryanodine receptor 2 (RyR2). For each gene, RNA mixture of Cas9 constructs (150 ng/μl Cas9 mRNA plus 6 ng/μl sgRNA) was microinjected into cytoplasm of pronuclear stage rabbit embryos (n = 290). We chose to use the concentration at 6 ng/μl for sgRNA because higher concentrations (12, 18, or 24 ng/μl) did not significantly improve the mutation rates (data not shown), and we speculate that higher quantity of sgRNA may increase the frequency of off-target events. Embryos were cultured in vitro, collected at blastocyst (BL) stage, and subjected to single embryo PCR and sequencing (n = 116) to identify mutations in the corresponding target locus. All nine sgRNAs generated mutations on their corresponding targeting loci with efficiencies ranging from 10% to nearly 100% (Figure 1D). High percentage (four out of nine) of the sgRNAs resulted in mutation rates higher than 50%; interestingly, bi-allelic mutations were also identified in these four, but not in those where mutation rates were 50% or lower (Figure 1D). Generation of KO rabbits with RNA-guided Cas9 nucleases. (A) Constructs of Cas9 RNA system used in this study. NLS, nuclear localization signal; bGH-pA, bovine growth hormone poly-A; PAM, protospacer adaptor motif. (B) Representative T7 endonuclease 1 assay results of newborn rabbits. T7 endonuclease 1 recognizes and cuts any mismatched bps in the double-strand DNA. Multiple bands on the gel indicate a successful gene targeting events (+). One single band indicates a WT genotype (−). (C) Sanger sequencing of targeted gene alleles in all founder KO rabbits, including CD36 (n = 11), APOE (n = 10), LDLR (n = 9), and RyR2 (n = 8) KO founders. Protospacer (target) sequence (20 nt) is shown in green on the top row for each gene, followed by 3 nt PAM (shown in red). For each gene, the number of founder animals is shown on the left column. Sequence information of the targeted alleles is shown in the middle column, where dash dots indicate deletions and italic red letters indicate insertions. The sizes of the insertions (+) or deletions (Δ) are shown on the right column. LDLR KO founder #1–5 showed the same Δ15 deletion in one allele; therefore they are consolidated into one row. Wt, wild-type. (D) In vitro gene targeting efficiency of Cas9 constructs. (E) Production efficiency of ApoE, LDLR, CD36, and RyR2 KO rabbits. After validating the in vitro gene targeting capacity of these Cas9 constructs, we continued to use four of them (APOE, CD36, LDLR, and RYR2) to produce KO rabbits. CD36, LDLR, and APOE KO rabbits are useful to study lipid metabolisms and atherosclerosis. The fourth line (RyR2 KO) will be used as a model to study heart arrhythmia. This is in recognition of the increasing demand for non-murine models for cardiovascular diseases in the research community. Cardiac physiology of rabbit better mimics that of human in a number of key areas than mouse does (Fan and Watanabe, 2003). For example, cholesteryl ester transfer protein, which plays a central role in the atherosclerotic process, is abundant in both human and rabbit plasma but absent in
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
Yang, H., Wang, H., Shivalila, C. S., Cheng, A. W., Shi, L., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.08.022 · Cited by 1,596
Research works printed but not linked: 6
- Chesne, 2002, Cloned rabbits produced by nuclear transfer from adult somatic cells, Nat. Biotechnol., 20, 366, 10.1038/nbt0402-366 · DOI · Paper page
- Conklin, 2013, Sculpting genomes with a hammer and chisel, Nat. Methods, 10, 839, 10.1038/nmeth.2608 · DOI
- Fan, 2003, Transgenic rabbits as therapeutic protein bioreactors and human disease models, Pharmacol. Ther., 99, 261, 10.1016/S0163-7258(03)00069-X · DOI · Paper page
- Gaj, 2013, ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering, Trends Biotechnol., 31, 397, 10.1016/j.tibtech.2013.04.004 · DOI · Paper page
- Li, 2013, Heritable gene targeting in the mouse and rat using a CRISPR-Cas system, Nat. Biotechnol., 31, 681, 10.1038/nbt.2661 · DOI · Paper page
- Li, 2013, Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems, Nat. Biotechnol., 31, 684, 10.1038/nbt.2652 · DOI · Paper page
Cited by
CRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
mRNA-based therapeutics--developing a new class of drugs
Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474
Wang, H.-X., Li, M., Lee, C. M., Chakraborty, S., Kim, H.-W., Bao, G., & Leong, K. W. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00799 · Cited by 560
Programmable RNA Tracking in Live Cells with CRISPR/Cas9
Nelles, D. A., Fang, M. Y., O’Connell, M. R., Xu, J. L., Markmiller, S. J., Doudna, J. A., & Yeo, G. W. (2016) · Cell · doi:10.1016/j.cell.2016.02.054 · Cited by 527
Self-citationAtherosclerosis: Known and unknown
Fan, J., & Watanabe, T. (2022) · Pathology International · doi:10.1111/pin.13202 · Cited by 523
Self-citation
Metadata
- Authors
- Yang, D., Xu, J., Zhu, T., Fan, J., Lai, L., Zhang, J., & Chen, Y. E.
- Venue
- Journal of Molecular Cell Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-02
- Volume
- 6
- Issue
- 1
- Pages
- 97-99
- ISSN
- 1674-2788 (ISSN-L)
- 1759-4685
- OpenAlex
- W2118412890
- Cited by
- 163
- References
- 4
- FWCI
- 8.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effective gene targeting in rabbits using RNA-guided Cas9 nucleases. https://app.cochat.ai/papers/10.1093/jmcb/mjt047
- The paper
- Yang, D., Xu, J., Zhu, T., Fan, J., Lai, L., Zhang, J., & Chen, Y. E. (2014). Effective gene targeting in rabbits using RNA-guided Cas9 nucleases. Journal of Molecular Cell Biology. https://doi.org/10.1093/jmcb/mjt047
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.